181 related articles for article (PubMed ID: 16548522)
41. Presenilin-dependent intramembrane proteolysis of CD44 leads to the liberation of its intracellular domain and the secretion of an Abeta-like peptide.
Lammich S; Okochi M; Takeda M; Kaether C; Capell A; Zimmer AK; Edbauer D; Walter J; Steiner H; Haass C
J Biol Chem; 2002 Nov; 277(47):44754-9. PubMed ID: 12223485
[TBL] [Abstract][Full Text] [Related]
42. Release of a membrane-bound death domain by gamma-secretase processing of the p75NTR homolog NRADD.
Gowrishankar K; Zeidler MG; Vincenz C
J Cell Sci; 2004 Aug; 117(Pt 18):4099-111. PubMed ID: 15280425
[TBL] [Abstract][Full Text] [Related]
43. Syntaxin 5 interacts specifically with presenilin holoproteins and affects processing of betaAPP in neuronal cells.
Suga K; Saito A; Tomiyama T; Mori H; Akagawa K
J Neurochem; 2005 Jul; 94(2):425-39. PubMed ID: 15998293
[TBL] [Abstract][Full Text] [Related]
44. Pharmacological evidences for DFK167-sensitive presenilin-independent gamma-secretase-like activity.
Sevalle J; Ayral E; Hernandez JF; Martinez J; Checler F
J Neurochem; 2009 Jul; 110(1):275-83. PubMed ID: 19457123
[TBL] [Abstract][Full Text] [Related]
45. Presenilin 1 stabilizes the C-terminal fragment of the amyloid precursor protein independently of gamma-secretase activity.
Pitsi D; Octave JN
J Biol Chem; 2004 Jun; 279(24):25333-8. PubMed ID: 15087467
[TBL] [Abstract][Full Text] [Related]
46. Presenilin-directed inhibitors of gamma-secretase trigger caspase 3 activation in presenilin-expressing and presenilin-deficient cells.
Alves da Costa C; Ayral E; Hernandez JF; St George-Hyslop P; Checler F
J Neurochem; 2004 Aug; 90(4):800-6. PubMed ID: 15287885
[TBL] [Abstract][Full Text] [Related]
47. Length and overall sequence of the PEN-2 C-terminal domain determines its function in the stabilization of presenilin fragments.
Prokop S; Haass C; Steiner H
J Neurochem; 2005 Jul; 94(1):57-62. PubMed ID: 15953349
[TBL] [Abstract][Full Text] [Related]
48. The presenilin C-terminus is required for ER-retention, nicastrin-binding and gamma-secretase activity.
Kaether C; Capell A; Edbauer D; Winkler E; Novak B; Steiner H; Haass C
EMBO J; 2004 Dec; 23(24):4738-48. PubMed ID: 15549135
[TBL] [Abstract][Full Text] [Related]
49. The Alzheimer's disease-associated gamma-secretase complex: functional domains in the presenilin 1 protein.
Laudon H; Winblad B; Näslund J
Physiol Behav; 2007 Sep; 92(1-2):115-20. PubMed ID: 17588625
[TBL] [Abstract][Full Text] [Related]
50. C-terminal PAL motif of presenilin and presenilin homologues required for normal active site conformation.
Wang J; Beher D; Nyborg AC; Shearman MS; Golde TE; Goate A
J Neurochem; 2006 Jan; 96(1):218-27. PubMed ID: 16305624
[TBL] [Abstract][Full Text] [Related]
51. Excess of nicastrin in brain results in heterozygosity having no effect on endogenous APP processing and amyloid peptide levels in vivo.
Brijbassi S; Amtul Z; Newbigging S; Westaway D; St George-Hyslop P; Rozmahel RF
Neurobiol Dis; 2007 Feb; 25(2):291-6. PubMed ID: 17071095
[TBL] [Abstract][Full Text] [Related]
52. Alzheimer presenilin-1 mutations dramatically reduce trimming of long amyloid β-peptides (Aβ) by γ-secretase to increase 42-to-40-residue Aβ.
Fernandez MA; Klutkowski JA; Freret T; Wolfe MS
J Biol Chem; 2014 Nov; 289(45):31043-52. PubMed ID: 25239621
[TBL] [Abstract][Full Text] [Related]
53. Pathological activity of familial Alzheimer's disease-associated mutant presenilin can be executed by six different gamma-secretase complexes.
Shirotani K; Tomioka M; Kremmer E; Haass C; Steiner H
Neurobiol Dis; 2007 Jul; 27(1):102-7. PubMed ID: 17560791
[TBL] [Abstract][Full Text] [Related]
54. Presenilin 1 is involved in the maturation of beta-site amyloid precursor protein-cleaving enzyme 1 (BACE1).
Kuzuya A; Uemura K; Kitagawa N; Aoyagi N; Kihara T; Ninomiya H; Ishiura S; Takahashi R; Shimohama S
J Neurosci Res; 2007 Jan; 85(1):153-65. PubMed ID: 17075903
[TBL] [Abstract][Full Text] [Related]
55. The cytoplasmic sequence of E-cadherin promotes non-amyloidogenic degradation of A beta precursors.
Agiostratidou G; Muros RM; Shioi J; Marambaud P; Robakis NK
J Neurochem; 2006 Feb; 96(4):1182-8. PubMed ID: 16417575
[TBL] [Abstract][Full Text] [Related]
56. Overexpression of calsenilin enhances gamma-secretase activity.
Jo DG; Jang J; Kim BJ; Lundkvist J; Jung YK
Neurosci Lett; 2005 Apr; 378(1):59-64. PubMed ID: 15763173
[TBL] [Abstract][Full Text] [Related]
57. In vitro reconstitution of gamma-secretase activity using yeast microsomes.
Yagishita S; Futai E; Ishiura S
Biochem Biophys Res Commun; 2008 Dec; 377(1):141-5. PubMed ID: 18834861
[TBL] [Abstract][Full Text] [Related]
58. C-terminal fragment of presenilin is the molecular target of a dipeptidic gamma-secretase-specific inhibitor DAPT (N-[N-(3,5-difluorophenacetyl)-L-alanyl]-S-phenylglycine t-butyl ester).
Morohashi Y; Kan T; Tominari Y; Fuwa H; Okamura Y; Watanabe N; Sato C; Natsugari H; Fukuyama T; Iwatsubo T; Tomita T
J Biol Chem; 2006 May; 281(21):14670-6. PubMed ID: 16569643
[TBL] [Abstract][Full Text] [Related]
59. Presenilin 1/gamma-secretase is associated with cadmium-induced E-cadherin cleavage and COX-2 gene expression in T47D breast cancer cells.
Park CS; Kim OS; Yun SM; Jo SA; Jo I; Koh YH
Toxicol Sci; 2008 Dec; 106(2):413-22. PubMed ID: 18791180
[TBL] [Abstract][Full Text] [Related]
60. Purification, pharmacological modulation, and biochemical characterization of interactors of endogenous human gamma-secretase.
Winkler E; Hobson S; Fukumori A; Dümpelfeld B; Luebbers T; Baumann K; Haass C; Hopf C; Steiner H
Biochemistry; 2009 Feb; 48(6):1183-97. PubMed ID: 19159235
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
